Rescale Achieves AWS Life Sciences Competency

Rescale has achieved AWS Life Sciences Competency partner status, complementing its existing AWS Manufacturing & Industrial and Government Competency recognitions, which underscores its expertise in delivering high-performance computing (HPC) services to life sciences customers. This achievement enhances Rescale's ability to support AWS life sciences clients by accelerating innovation and digital transformation in research and development (R&D) programs. The partnership aims to address the challenges faced by biopharmaceutical companies, particularly the high costs and risks associated with drug discovery, by offering scalable, on-demand supercomputing infrastructure to facilitate computational science efforts. Rescale simplifies the complexities of HPC cloud migration by providing a platform that supports a wide range of applications and computing architectures, enabling life sciences organizations to conduct extensive simulations in areas such as computer-aided drug design and genomic sequencing. This collaboration is positioned to help biopharmaceutical companies streamline their R&D processes, reduce costs, and bring new therapies to market more efficiently.